Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Pediatric Psoriasis Study

This study is currently closed to enrollment.

Study of Risankizumab in Pediatric Patients with Moderate to Severe Plaque Psoriasis

baby feet with red rash

 

AGE: 6-18 years old
SEX AT BIRTH: All
TYPE: Investigational Treatment Study
CONDITION: Plaque psoriasis
HEALTHY PARTICIPANTS: No
LOCATION: University Hospitals Medical Centers

Study Purpose

The purpose of this study is to evaluate Risankizumab compared to Ustekinumab for the treatment of moderate to severe plaque psoriasis who are pediatric candidates for systemic therapy.


STUDY ID#

  • STUDY20210431